AWARD
65 -- Reuseable Core Biopsy Instrument -- BARD Peripheral Vascular, Inc. FAR 13.106-1(b)(1)
- Notice Date
- 11/6/2009
- Notice Type
- Award Notice
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- Department of Veterans Affairs;Contracting Officer (620);Jonathan M. Wainwright Memorial VAMC;77 Wainwright Drive;Walla Walla WA 99362-3994
- ZIP Code
- 99362-3994
- Archive Date
- 11/15/2009
- Point of Contact
- Charlene DuncanContracting Officer
- E-Mail Address
-
Reusable Core Biopsy Instruments
(Charlene)
- Small Business Set-Aside
- N/A
- Award Number
- VA687-A09001
- Award Date
- 11/5/2009
- Awardee
- BARD PERIPHERAL VASCULAR INC;1625 W 3RD ST;TEMPE;AZ;852812438
- Award Amount
- 7,115.00
- Line Number
- 1
- Description
- The VAMC, Walla Walla, WA, has awarded a single source contract to BARD Peripheral Vascular, Inc. for 5 each reusable core biopsy instruments in the amount of $7,115.00. The contract is in accordance with FAR Part 13 and the single source determination and findings is in accordance with FAR Part 13.106-1(b)(1). The text of the determination follows. For more information, contact Charlene Duncan at charlene.duncan@va.gov. DETERMINATION AND FINDINGS / Only One Source Reasonably Available (FAR 13.106-1(B)(1)) / Reusable Core Biopsy Instruments The VAMC, Walla Walla, is in need of additional biopsy instruments. Based upon the following findings and subsequent determination, the proposed contract will be a single source contract in accordance with FAR 13.106-1(b)(1). FINDINGS (1)The VAMC, Walla Walla, already has these particular biopsy instruments on hand; (2) The VAMC, Walla Walla, maintains a small supply of the biopsy needles in stock; (3) The biopsy instruments are proprietary to BARD Biopsy Systems and only BARD biopsy needles will fit these instruments; (4) The medical personnel that take biopsy samples have been trained on these particular biopsy instruments; (5) Procurement of different biopsy instruments would require stocking of multiple brands of biopsy needs and additional training of staff; (6) Use of multiple biopsy instruments increases the risk for error; and (7) The total estimated value of the acquisition is $7,115.00. DETERMINATION Based upon the above findings and as authorized by FAR 13.105-1(b)(1), I have determined that the only reasonable source for these biopsy instruments is BARD Peripheral Vascular, Inc. Procurement of the biopsy instruments from BARD is in the best interest of the government. /s/ Charlene Duncan, Contracting Officer, 11/05/2009
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/VA/WWVAMC687/WWVAMC687/Awards/VA687-A09001.html)
- Record
- SN01999479-W 20091108/091106235237-66250feafb5dd8a180433529a37069d7 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |